• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine (LAIV) and Inactivated Influenza Vaccine (IIV) i

tetano

Editor, Senior Moderator
Clin Vaccine Immunol. 2016 Nov 9. pii: CVI.00414-16. [Epub ahead of print]
[h=1]Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine (LAIV) and Inactivated Influenza Vaccine (IIV) in Adults.[/h] Hoft DF[SUP]1[/SUP], Lottenbach KR[SUP]2[/SUP], Blazevic A[SUP]2[/SUP], Turan A[SUP]2[/SUP], Blevins TP[SUP]2[/SUP], Pacatte TP[SUP]2[/SUP], Yu Y[SUP]2[/SUP], Mitchell MC[SUP]2[/SUP], Hoft SG[SUP]2[/SUP], Belshe RB[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Both live attenuated influenza vaccine (LAIV) and inactivated influenza vaccines (IIV) induce protective immunity against influenza. There is evidence that LAIV induces superior protection in children, whereas IIV may induce superior protection in adults. The immune mechanisms responsible for these differences have not been identified. We previously compared LAIV and IIV in young children 6-36 months of age, and demonstrated that while both induced similar hemagglutination-inhibiting (HAI) antibody responses, only LAIV induced significant increases in T cell responses. Here, 37 healthy adult subjects 18-49 years of age were randomized to receive seasonal influenza vaccination with LAIV or IIV. Influenza-specific HAI, T cell and secretory IgA (sIgA) responses were studied pre- and post-vaccination.In contrast to responses seen in young children, LAIV induced only minimal increases in serum HAI responses in adults, significantly lower than responses induced by IIV. Both LAIV and IIV similarly induced only transient T cell responses in adults reactive with whole replication competent virus. In contrast, influenza-specific sIgA responses were more strongly induced by LAIV compared to IIV vaccine.Our previous studies suggest that LAIV vaccine may be more protective than IIV in young children not previously exposed to influenza or influenza vaccines due to increased vaccine-induced T cell and/or secretory IgA responses. Our current work suggests that in adults with extensive and partially cross-reactive pre-existing influenza immunity, LAIV boosting of sIgA responses reactive with hemagglutinin (HA) and non-HA antigenic targets expressed by circulating influenza strains may be an important additional mechanism of vaccine-induced immunity.
Copyright ? 2016, American Society for Microbiology. All Rights Reserved.


PMID: 27847366 DOI: 10.1128/CVI.00414-16
[PubMed - as supplied by publisher]
 
Back
Top Bottom